$307.63
+5.55
(+1.84%)▲
1.61%
Downside
Day's Volatility :1.84%
Upside
0.24%
38.91%
Downside
52 Weeks Volatility :39.04%
Upside
0.2%
Period | Corvel Corp | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 26.58% | 6.5% | 0.0% |
6 Months | 33.12% | 7.1% | 0.0% |
1 Year | 46.23% | 9.8% | 0.0% |
3 Years | 120.09% | 14.2% | -20.2% |
Market Capitalization | 5.2B |
Book Value | $14.46 |
Earnings Per Share (EPS) | 4.44 |
PE Ratio | 68.04 |
PEG Ratio | 0.0 |
Wall Street Target Price | 0.0 |
Profit Margin | 9.59% |
Operating Margin TTM | 10.9% |
Return On Assets TTM | 14.01% |
Return On Equity TTM | 33.9% |
Revenue TTM | 795.3M |
Revenue Per Share TTM | 46.45 |
Quarterly Revenue Growth YOY | 11.799999999999999% |
Gross Profit TTM | 152.1M |
EBITDA | 121.4M |
Diluted Eps TTM | 4.44 |
Quarterly Earnings Growth YOY | 0.09 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Downside of 100.0%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 595.7M | ↑ 6.7% |
Net Income | 46.7M | ↑ 30.84% |
Net Profit Margin | 7.84% | ↑ 1.45% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 592.2M | ↓ 0.59% |
Net Income | 47.4M | ↑ 1.44% |
Net Profit Margin | 8.0% | ↑ 0.16% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 552.6M | ↓ 6.68% |
Net Income | 46.4M | ↓ 2.16% |
Net Profit Margin | 8.39% | ↑ 0.39% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 646.2M | ↑ 16.93% |
Net Income | 66.4M | ↑ 43.26% |
Net Profit Margin | 10.28% | ↑ 1.89% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 718.6M | ↑ 11.19% |
Net Income | 66.4M | ↓ 0.07% |
Net Profit Margin | 9.24% | ↓ 1.04% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 795.3M | ↑ 10.68% |
Net Income | 76.3M | ↑ 14.9% |
Net Profit Margin | 9.59% | ↑ 0.35% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 179.4M | ↑ 1.1% |
Net Income | 16.8M | ↑ 14.96% |
Net Profit Margin | 9.39% | ↑ 1.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 185.4M | ↑ 3.38% |
Net Income | 18.2M | ↑ 7.83% |
Net Profit Margin | 9.8% | ↑ 0.41% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 190.3M | ↑ 2.59% |
Net Income | 19.8M | ↑ 9.0% |
Net Profit Margin | 10.41% | ↑ 0.61% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 195.5M | ↑ 2.77% |
Net Income | 19.9M | ↑ 0.47% |
Net Profit Margin | 10.18% | ↓ 0.23% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 202.3M | ↑ 3.47% |
Net Income | 17.1M | ↓ 14.09% |
Net Profit Margin | 8.45% | ↓ 1.73% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 207.2M | ↑ 2.44% |
Net Income | 19.5M | ↑ 13.8% |
Net Profit Margin | 9.39% | ↑ 0.94% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 318.0M | ↑ 16.06% |
Total Liabilities | 123.2M | ↑ 19.82% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 416.3M | ↑ 30.89% |
Total Liabilities | 226.5M | ↑ 83.87% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 424.8M | ↑ 2.04% |
Total Liabilities | 204.4M | ↓ 9.8% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 415.2M | ↓ 2.24% |
Total Liabilities | 202.9M | ↓ 0.74% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 393.9M | ↓ 5.14% |
Total Liabilities | 191.7M | ↓ 5.47% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 474.4M | ↑ 20.43% |
Total Liabilities | 226.8M | ↑ 18.27% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 407.7M | ↑ 1.95% |
Total Liabilities | 212.9M | ↑ 5.36% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 393.9M | ↓ 3.38% |
Total Liabilities | 191.7M | ↓ 9.93% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 417.6M | ↑ 6.0% |
Total Liabilities | 210.6M | ↑ 9.83% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 434.1M | ↑ 3.96% |
Total Liabilities | 211.5M | ↑ 0.45% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 445.0M | ↑ 2.51% |
Total Liabilities | 211.5M | ↓ 0.04% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 474.4M | ↑ 6.61% |
Total Liabilities | 226.8M | ↑ 7.24% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 78.6M | ↑ 26.53% |
Investing Cash Flow | -15.3M | ↓ 44.84% |
Financing Cash Flow | -27.4M | ↑ 275.5% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 80.8M | ↑ 2.78% |
Investing Cash Flow | -32.4M | ↑ 111.86% |
Financing Cash Flow | -57.0M | ↑ 107.69% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 94.4M | ↑ 16.77% |
Investing Cash Flow | -17.2M | ↓ 46.72% |
Financing Cash Flow | -20.6M | ↓ 63.76% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 67.2M | ↓ 28.77% |
Investing Cash Flow | -29.8M | ↑ 72.93% |
Financing Cash Flow | -79.6M | ↑ 285.68% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 82.3M | ↑ 22.41% |
Investing Cash Flow | -26.3M | ↓ 11.73% |
Financing Cash Flow | -82.1M | ↑ 3.18% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 29.7M | ↑ 205.62% |
Investing Cash Flow | -5.8M | ↑ 14.99% |
Financing Cash Flow | -21.6M | ↓ 7.8% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 12.8M | ↓ 57.03% |
Investing Cash Flow | -7.2M | ↑ 24.06% |
Financing Cash Flow | -12.3M | ↓ 42.85% |
Sell
Neutral
Buy
Corvel Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Corvel Corp | 20.13% | 33.12% | 46.23% | 120.09% | 225.94% |
![]() Willis Towers Watson Plc | 5.29% | 11.27% | 19.18% | 34.71% | 39.37% |
![]() Marsh & Mclennan Companies, Inc. | 2.5% | 11.95% | 12.53% | 46.34% | 110.89% |
![]() Arthur J Gallagher & Co. | 8.07% | 17.57% | 24.67% | 95.39% | 196.73% |
![]() Aon Plc | 3.53% | -0.98% | -12.4% | 18.84% | 53.65% |
![]() Brown & Brown Inc. | 7.56% | 26.73% | 35.98% | 79.1% | 167.74% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Corvel Corp | 68.04 | 68.04 | 0.0 | 0.0 | 0.34 | 0.14 | NA | 14.46 |
![]() Willis Towers Watson Plc | 26.94 | 26.94 | 1.12 | 16.27 | 0.11 | 0.04 | 0.01 | 92.84 |
![]() Marsh & Mclennan Companies, Inc. | 26.95 | 26.95 | 2.43 | 8.76 | 0.32 | 0.08 | 0.02 | 27.17 |
![]() Arthur J Gallagher & Co. | 55.8 | 55.8 | 2.09 | 10.15 | 0.1 | 0.03 | 0.01 | 51.72 |
![]() Aon Plc | 23.32 | 23.32 | 1.52 | 15.43 | 1.76 | 0.07 | 0.01 | -0.67 |
![]() Brown & Brown Inc. | 28.12 | 28.12 | 4.41 | 3.67 | 0.18 | 0.05 | 0.01 | 21.14 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Corvel Corp | NA | $5.2B | 225.94% | 68.04 | 9.59% |
![]() Willis Towers Watson Plc | Buy | $27.3B | 39.37% | 26.94 | 10.88% |
![]() Marsh & Mclennan Companies, Inc. | Hold | $106.9B | 110.89% | 26.95 | 16.97% |
![]() Arthur J Gallagher & Co. | Buy | $59.9B | 196.73% | 55.8 | 10.83% |
![]() Aon Plc | Hold | $65.0B | 53.65% | 23.32 | 19.04% |
![]() Brown & Brown Inc. | Buy | $27.8B | 167.74% | 28.12 | 22.33% |
Insights on Corvel Corp
Revenue is up for the last 16 quarters, 129.6M → 207.23M (in $), with an average increase of 3.1% per quarter
Netprofit is up for the last 2 quarters, 17.09M → 19.45M (in $), with an average increase of 12.1% per quarter
Kayne Anderson Rudnick Investment Management LLC
BlackRock Inc
Vanguard Group Inc
Renaissance Technologies Corp
Dimensional Fund Advisors, Inc.
State Street Corporation
together, let's do more. corvel is a leader of risk and healthcare management solutions to employers, third party administrators, insurance companies and government agencies. we are publicly traded (nasdaq:crvl) and annual revenues exceeded $493 million in fy2015. our continued customer growth is a testament to our financial stability and our significant investments in new systems and technologies allows us to continue to deliver industry-leading solutions to the marketplace. corvel has approximately 3,500 associates who serve more than 2,000 customers through a national branch office network covering all 50 states.
Organization | Corvel Corp |
Employees | 4870 |
CEO | Mr. Victor Gordon Clemons Sr. |
Industry | Finance |
Outfront Media Inc.
$307.63
+1.84%
Blackrock Short Duration Bond Etf
$307.63
+1.84%
Helmerich & Payne, Inc.
$307.63
+1.84%
Crane Nxt Co
$307.63
+1.84%
Liberty Global Plc - Class C Shares
$307.63
+1.84%
Waystar Holding Corp.
$307.63
+1.84%
Apogee Therapeutics
$307.63
+1.84%
Wd-40 Co
$307.63
+1.84%
Nnn Reit Inc.
$307.63
+1.84%